Keiji Hirata
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 35
- Cancer Treatment and Pharmacology 15
- Pancreatic and Hepatic Oncology Research 14
- Physiology top 2%
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research 16
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 17
- Hepatology top 5%
-
- Genetic factors in colorectal cancer 23
-
- Gastric Cancer Management and Outcomes 21
-
- Glycosylation and Glycoproteins Research 12
- Co-authors
- Michael H. NathansonNorihiro SatoShiro KohiKazunori ShibaoAtsuhiro KogaYoshifumi NakayamaHideaki ItohXiaobo Cheng
- Cited by
- OncologyPhysiologyCell Biology
- Journals
- Journal of Clinical Oncology (12 papers)International Journal of Clinical Oncology (5 papers)Annals of Gastroenterological Surgery (5 papers)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Keiji Hirata
172 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 122
- Oncology 1.1k
- Physiology 113
- Cell Biology 377
- Cancer Research 333
- Hepatology 175
Countries citing papers authored by Keiji Hirata
This map shows the geographic impact of Keiji Hirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Hirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Hirata more than expected).
Fields of papers citing papers by Keiji Hirata
This network shows the impact of papers produced by Keiji Hirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Hirata. The network helps show where Keiji Hirata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keiji Hirata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 1 | |
| 5 | KRAS野生型転移性結腸直腸癌(太平洋研究)患者におけるフルオロピリミジンの有無による第2線パニツムマブおよびイリノテカンの多施設オープンラベル無作為化第II相試験【JST・京大機械翻訳】 | 2019 | 1 |
| 6 | The study on the safety and feasibility of gastroenterological surgery in patients undergoing antithrombotic therapy: Study protocol for a multicenter prospective cohort analysis (The GSATT Study) | 2019 | 3 |
| 7 | [A Case of Small Cell Carcinoma of the Pancreas]. | 2019 | 0 |
| 8 | 2017 | 11 | |
| 9 | 2017 | 7 | |
| 10 | Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 study. | 2014 | 9 |
| 11 | 2014 | 0 | |
| 12 | Abdominal Wall Abscess and Sepsis induced by Stercoral Penetration of a Sigmoid Colostomy-Report of a Case- | 2009 | 1 |
| 13 | Development of Assistant System for Ensemble in t-Room | 2009 | 5 |
| 14 | 2009 | 3 | |
| 15 | Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma. | 2007 | 16 |
| 16 | 2007 | 1 | |
| 17 | 2006 | 5 | |
| 18 | Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer. | 2005 | 15 |
| 19 | Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer. | 2005 | 19 |
| 20 | [MASSIVE DOSES OF MITOMYCIN DURING SURGERY--THEORY AND RESULTS DURING PALLIATIVE EXCISION IN STOMACH CANCER]. | 1964 | 1 |
About Keiji Hirata
Keiji Hirata is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 189 papers that have together received 2.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Genetic factors in colorectal cancer (23 papers), Gastric Cancer Management and Outcomes (21 papers), Cancer Genomics and Diagnostics (17 papers), Proteoglycans and glycosaminoglycans research (16 papers), Cancer Treatment and Pharmacology (15 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Glycosylation and Glycoproteins Research (12 papers). The work is most often cited by research in Oncology (1.1k citations), Physiology (113 citations) and Cell Biology (377 citations). Keiji Hirata has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Michael H. Nathanson, Norihiro Sato, Shiro Kohi, Kazunori Shibao, Atsuhiro Koga, Yoshifumi Nakayama, Hideaki Itoh, Xiaobo Cheng, Naoki Nagata and Noritaka Minagawa. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Clinical Oncology, Annals of Gastroenterological Surgery, Journal of Gastroenterology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.